Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
04/21/2024 05:02 PM
Pennsylvania House of Representatives
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search

House of Representatives
Session of 2021 - 2022 Regular Session


Posted: December 9, 2020 10:34 AM
From: Representative Jeanne McNeill and Rep. Mike Zabel
To: All House members
Subject: Insulin Cap Price
When insulin was discovered in 1923 as a treatment for diabetes, the patent for the drug was sold for $3. The founders believed profiting from a drug that would save millions of lives was medically unethical and an immense conflict of interest for healthcare. Today, we are all too familiar with skyrocketing prescription drug prices, and insulin is consistently one of the top offenders in a country where 10% of its population is dependent on the drug to survive.
In 2016, the average monthly out-of-pocket cost was $450, with some individuals reporting costs upwards of $1,000 a month and no signs from manufacturers that the uptick is slowing down. The number of horrifying stories of individuals who are left to decide between paying their rent or buying groceries and accessing the life-sustaining drug are endless in our state. More commonly, people are forced to ration their doses, subjecting them to a premature, preventable death – an outcome resulting from the reprehensible price gouging they are faced with every day.
Without immediate intervention, the price of insulin is forecasted to reach an average of close to $13,000 per patient in just three years. As such, our bill would set a mandatory price cap on the monthly cost of insulin for patients at $100 a month and call upon the attorney general to investigate the choices made by pharmaceutical companies that have allowed us to reach this point of financial crisis.
Please join us in supporting this life-saving legislation and the 12 other states that have taken swift action to protect consumers. 

Introduced as HB460